Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Evidence-based practice and patient-centered care: Doing both well.

Engle RL, Mohr DC, Holmes SK, Seibert MN, Afable M, Leyson J, Meterko M.

Health Care Manage Rev. 2019 Jun 20. doi: 10.1097/HMR.0000000000000254. [Epub ahead of print]

PMID:
31233424
2.

Is Variation in Resident-Centered Care and Quality Performance Related to Health System Factors in Veterans Health Administration Nursing Homes?

Sullivan JL, Engle RL, Tyler D, Afable MK, Gormley K, Shwartz M, Adjognon O, Parker VA.

Inquiry. 2018 Jan-Dec;55:46958018787031. doi: 10.1177/0046958018787031.

3.

Cardiology electronic consultation (e-consult) use by primary care providers at VA medical centres in New England.

Kim EJ, Orlander JD, Afable M, Pawar S, Cutrona SL, Simon SR, Strymish J, Vimalananda VG.

J Telemed Telecare. 2019 Jul;25(6):370-377. doi: 10.1177/1357633X18774468. Epub 2018 May 12.

PMID:
29754562
4.

Staff-perceived Conflict between Resident-centered Care and Quality in the Skilled Nursing Facility: Are Both Possible?

Parker V, Engle RL, Afable MK, Tyler DA, Gormley K, Stolzmann K, Shwartz M, Sullivan JL.

Clin Gerontol. 2019 May-Jun;42(3):267-276. doi: 10.1080/07317115.2018.1467522. Epub 2018 May 7.

PMID:
29733754
5.

Innovative Use Of Electronic Consultations In Preoperative Anesthesiology Evaluation At VA Medical Centers In New England.

Afable MK, Gupte G, Simon SR, Shanahan J, Vimalananda V, Kim EJ, Strymish J, Orlander JD.

Health Aff (Millwood). 2018 Feb;37(2):275-282. doi: 10.1377/hlthaff.2017.1087.

PMID:
29401018
6.

Identifying barriers to culture change: A qualitative analysis of the obstacles to delivering resident-centered care.

Engle RL, Tyler DA, Gormley KE, Afable MK, Curyto K, Adjognon OL, Parker VA, Sullivan JL.

Psychol Serv. 2017 Aug;14(3):316-326. doi: 10.1037/ser0000169.

PMID:
28805416
7.

Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).

Sanikommu SR, Clemente MJ, Chomczynski P, Afable MG 2nd, Jerez A, Thota S, Patel B, Hirsch C, Nazha A, Desamito J, Lichtin A, Pohlman B, Sekeres MA, Radivoyevitch T, Maciejewski JP.

Leuk Lymphoma. 2018 Feb;59(2):416-422. doi: 10.1080/10428194.2017.1339880. Epub 2017 Jun 20.

PMID:
28633612
8.

A Longitudinal Assessment of the Effect of Resident-Centered Care on Quality in Veterans Health Administration Community Living Centers.

Sullivan JL, Shwartz M, Stolzmann K, Afable MK, Burgess JF.

Health Serv Res. 2018 Jun;53(3):1819-1833. doi: 10.1111/1475-6773.12688. Epub 2017 Mar 28.

9.

The role of organizational structure in readiness for change: A conceptual integration.

Benzer JK, Charns MP, Hamdan S, Afable M.

Health Serv Manage Res. 2017 Feb;30(1):34-46. doi: 10.1177/0951484816682396. Epub 2016 Dec 14.

PMID:
28166670
10.

Electronic Consultations (E-consults): Advancing Infectious Disease Care in a Large Veterans Affairs Healthcare System.

Strymish J, Gupte G, Afable MK, Gupta K, Kim EJ, Vimalananda V, Simon SR, Orlander JD.

Clin Infect Dis. 2017 Apr 15;64(8):1123-1125. doi: 10.1093/cid/cix058.

PMID:
28158475
11.

Identifying and overcoming implementation challenges: Experience of 59 noninstitutional long-term services and support pilot programs in the Veterans Health Administration.

Sullivan JL, Adjognon OL, Engle RL, Shin MH, Afable MK, Rudin W, White B, Shay K, Lukas CV.

Health Care Manage Rev. 2018 Jul/Sep;43(3):193-205. doi: 10.1097/HMR.0000000000000152.

12.

Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment.

Afable M, Caimi PF, Hosing C, de Lima M, Khouri I, William BM, Nieto Y, Cooper BW, Anderlini P, Gerson SL, Lazarus HM, Champlin R, Popat U.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1529-1531. doi: 10.1016/j.bbmt.2015.04.022. Epub 2015 Apr 30.

13.

Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes.

Clemente MJ, Przychodzen B, Jerez A, Dienes BE, Afable MG, Husseinzadeh H, Rajala HL, Wlodarski MW, Mustjoki S, Maciejewski JP.

Blood. 2013 Dec 12;122(25):4077-85. doi: 10.1182/blood-2013-05-506386. Epub 2013 Oct 22.

14.

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.

Jerez A, Clemente MJ, Makishima H, Rajala H, Gómez-Seguí I, Olson T, McGraw K, Przychodzen B, Kulasekararaj A, Afable M, Husseinzadeh HD, Hosono N, LeBlanc F, Lagström S, Zhang D, Ellonen P, Tichelli A, Nissen C, Lichtin AE, Wodnar-Filipowicz A, Mufti GJ, List AF, Mustjoki S, Loughran TP Jr, Maciejewski JP.

Blood. 2013 Oct 3;122(14):2453-9. doi: 10.1182/blood-2013-04-494930. Epub 2013 Aug 7. Erratum in: Blood. 2014 May 22;123(21):3364.

15.

Explaining differences in hepatitis C between U.S. veterans and nonveterans in treatment for substance abuse: results from a regression decomposition.

Heslin KC, Guerrero EG, Mitchell MN, Afable MK, Dobalian A.

Subst Use Misuse. 2013 Jul;48(10):854-62. doi: 10.3109/10826084.2013.808222.

PMID:
23869458
16.

Personal medication preparedness among veteran and nonveteran men and women in the California population.

Heslin KC, Gin JL, Afable MK, Ricci K, Dobalian A.

Prehosp Disaster Med. 2013 Aug;28(4):359-66. doi: 10.1017/S1049023X13003506. Epub 2013 Apr 26.

PMID:
23731616
17.

Using exercises to identify Veterans Health Administration priorities for disaster response: findings from the New Madrid Earthquake training exercise.

Gin JL, Chan EW, Brewster P, Mitchell MN, Ricci KA, Afable MK, Dobalian A.

J Public Health Manag Pract. 2013 Mar-Apr;19(2):126-32. doi: 10.1097/PHH.0b013e318256142a.

PMID:
23358290
18.

A case of mistaken identity: When lupus masquerades as primary myelofibrosis.

Hasrouni E, Rogers HJ, Tabarroki A, Visconte V, Traina F, Afable M, Sekeres MA, Maciejewski JP, Tiu RV.

SAGE Open Med Case Rep. 2013 Aug 20;1:2050313X13498709. doi: 10.1177/2050313X13498709. eCollection 2013.

19.

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.

Sekeres MA, Tiu RV, Komrokji R, Lancet J, Advani AS, Afable M, Englehaupt R, Juersivich J, Cuthbertson D, Paleveda J, Tabarroki A, Visconte V, Makishima H, Jerez A, Paquette R, List AF, Maciejewski JP.

Blood. 2012 Dec 13;120(25):4945-51. doi: 10.1182/blood-2012-06-434639. Epub 2012 Aug 22.

20.

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.

Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, Olson T, Przychodzen B, Afable M, Gomez-Segui I, Guinta K, Durkin L, Hsi ED, McGraw K, Zhang D, Wlodarski MW, Porkka K, Sekeres MA, List A, Mustjoki S, Loughran TP, Maciejewski JP.

Blood. 2012 Oct 11;120(15):3048-57. doi: 10.1182/blood-2012-06-435297. Epub 2012 Aug 2.

21.

Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation.

Sugimori C, Padron E, Caceres G, Shain K, Sokol L, Zhang L, Tiu R, O'Keefe CL, Afable M, Clemente M, Lee JM, Maciejewski JP, List AF, Epling-Burnette PK, Araten DJ.

Blood Cancer J. 2012 Mar;2(3):e63. doi: 10.1038/bcj.2012.7. Epub 2012 Mar 23. No abstract available.

22.

Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.

Kar SA, Jankowska A, Makishima H, Visconte V, Jerez A, Sugimoto Y, Muramatsu H, Traina F, Afable M, Guinta K, Tiu RV, Przychodzen B, Sakaguchi H, Kojima S, Sekeres MA, List AF, McDevitt MA, Maciejewski JP.

Haematologica. 2013 Jan;98(1):107-13. doi: 10.3324/haematol.2012.064048. Epub 2012 Jul 6.

23.

Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.

Sugimoto Y, Sekeres MA, Makishima H, Traina F, Visconte V, Jankowska A, Jerez A, Szpurka H, O'Keefe CL, Guinta K, Afable M, Tiu R, McGraw KL, List AF, Maciejewski J.

J Hematol Oncol. 2012 Mar 5;5:4. doi: 10.1186/1756-8722-5-4.

24.

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP.

Blood. 2012 Apr 5;119(14):3203-10. doi: 10.1182/blood-2011-12-399774. Epub 2012 Feb 9.

25.

Clonal evolution in aplastic anemia.

Afable MG 2nd, Tiu RV, Maciejewski JP.

Hematology Am Soc Hematol Educ Program. 2011;2011:90-5. doi: 10.1182/asheducation-2011.1.90. Review.

PMID:
22160018
26.

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.

Afable MG 2nd, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP.

Haematologica. 2011 Sep;96(9):1269-75. doi: 10.3324/haematol.2011.042622. Epub 2011 May 23.

27.

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP.

Blood. 2011 Jun 23;117(25):6876-84. doi: 10.1182/blood-2010-11-314393. Epub 2011 Apr 28.

28.

Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria.

O'Keefe CL, Sugimori C, Afable M, Clemente M, Shain K, Araten DJ, List A, Epling-Burnette PK, Maciejewski JP.

Leukemia. 2011 Feb;25(2):379-82. doi: 10.1038/leu.2010.274. Epub 2010 Nov 30. No abstract available.

PMID:
21116280
29.

Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes.

Sekeres MA, O'Keefe C, List AF, Paulic K, Afable M 2nd, Englehaupt R, Maciejewski JP.

Am J Hematol. 2011 Jan;86(1):102-3. doi: 10.1002/ajh.21891.

30.

A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.

Sekeres MA, Maciejewski JP, Erba HP, Afable M, Englehaupt R, Sobecks R, Advani A, Seel S, Chan J, Kalaycio ME.

Cancer. 2011 Mar 15;117(6):1253-61. doi: 10.1002/cncr.25686. Epub 2010 Oct 19.

31.

Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes.

Sekeres MA, List AF, Cuthbertson D, Paquette R, Ganetzky R, Latham D, Paulic K, Afable M, Saba HI, Loughran TP Jr, Maciejewski JP.

J Clin Oncol. 2010 May 1;28(13):2253-8. doi: 10.1200/JCO.2009.26.0745. Epub 2010 Mar 30. Erratum in: J Clin Oncol. 2010 Jun 20;28(18):3098. Ganetsky, Rebecca [corrected to Ganetzky, Rebecca].

32.

Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.

Mohan SR, Clemente MJ, Afable M, Cazzolli HN, Bejanyan N, Wlodarski MW, Lichtin AE, Maciejewski JP.

Haematologica. 2009 Oct;94(10):1407-14. doi: 10.3324/haematol.2009.009191.

33.

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP.

Blood. 2009 Jun 18;113(25):6403-10. doi: 10.1182/blood-2009-02-205690. Epub 2009 Apr 16.

34.

Severe fatigue: could it be aplastic anemia?

Afable MG 2nd, Lyon DE.

Clin J Oncol Nurs. 2008 Aug;12(4):569-73. doi: 10.1188/08.CJON.569-573. Review. No abstract available.

Supplemental Content

Loading ...
Support Center